4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
AIM Vaccine Co., Ltd. (6660) operates in the Biotechnology industry and is headquartered in Beijing, China with about 1,466 employees. Its market capitalization is roughly CNY 2 billion. In the fiscal year ended 2025-12-31, 6660 reported CNY 1.2B in revenue and (CNY 676M) in net income.
AIM Vaccine Co., Ltd. engages in the research and development, manufacture, and sale of vaccine products for human use in the People's Republic of China and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 1.2B | CNY 1.3B | CNY 1.2B | CNY 1.3B | — |
| Gross Profit | CNY 760M | CNY 954M | CNY 901M | CNY 1.0B | — |
| Operating Income (EBIT) | (CNY 192M) | (CNY 211M) | (CNY 451M) | (CNY 381M) | — |
| Net Income | (CNY 676M) | (CNY 277M) | (CNY 1.3B) | (CNY 320M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 6.5B | CNY 7.3B | CNY 7.3B | CNY 8.9B | — |
| Total Liabilities | CNY 3.6B | CNY 3.7B | CNY 3.4B | CNY 3.0B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6660 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms